Therefore, we conducted this cohort study to compare the outcomes of all-cause mortality, hospitalization for COPD, bacterial pneumonia, ventilator use, lung cancer, and severe hypoglycemia in people with coexisting T2D and COPD with or without receiving insulin therapy. The gene discussed is INS; the disease is Hypoglycemia.